The first clinical study is underway at Amazon

Amazon is taking the next step in healthcare – the shipping giant is reportedly working on a vaccine against cancer. A first clinical study is said to have already started.

Experts have suspected for some time that Amazon has the healthcare sector firmly in its sights. So does economist Scott Galloway, who predicted back in 2020 that Amazon “will be the world’s fastest growing healthcare company by 2025.”

The latest report about the efforts of the mail order company in the health sector are therefore hardly surprising. Accordingly, Amazon is involved in the development of a vaccine against cancer.

How far is Amazon’s cancer vaccine?

As Business Insider reports Amazon is working with the Fred Huchinson Cancer Center in Seattle on a vaccine against cancer. This could one day be used for skin and breast cancer. The main focus will be on stage IIC-IV melanoma and HER2-negative breast cancer.

However, the vaccine is currently in the testing phase. The team is currently looking for subjects for a clinical study.

The US Food and Drug Administration (FDA) has already approved human testing. The aim is to develop an alternative to chemotherapy.

What is known about the study?

According to the report of Business Insider the study is already in full swing. It is scheduled to continue until November 2023. For the first phase of the clinical study, 20 patients aged 18 and over are planned.

From the FDA records go loud Business Insider shows that Amazon is also listed as an “employee” in addition to Fred Hutchinson as a sponsor. Both sides have this information opposite BI approved.

What does Amazon say about its vaccine against cancer?

If implemented successfully, the planned vaccine could function in a similar way to vaccination against the coronavirus. The substance is supposed to train the immune system so that it recognizes cancer cells and attacks them accordingly.

But it could be quite a while before it is actually used in medicine. An Amazon spokesman told Business Insiderthat it is a “long, multi-year process”.

Should progress be made here, the company would be “open to collaboration with other healthcare organizations.”

Also interesting: